Chemical Suppression of KLK5 and KLK7 Rescues Barrier Integrity in a Netherton Syndrome Model
Exp Dermatol
.
2025 Feb;34(2):e70055.
doi: 10.1111/exd.70055.
Authors
Shi Yun Yeo
1
,
Tanya Low
1
,
Aaron Zefrin Fernandis
1
Affiliation
1
Quantitative Biosciences, MSD International GmbH, Singapore Branch, Singapore.
PMID:
39973120
DOI:
10.1111/exd.70055
No abstract available
Grants and funding
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc., Rahway, NJ, USA